Delhi High Court Raises Safety Concerns Over HPV Vaccine Rollout Under UIP
The Delhi High Court has raised concerns over the Centre's rollout of Merck's HPV vaccine Gardasil under the Universal Immunisation Programme, citing safety issues and previous adverse events reported during earlier trials. A petition filed by Dr. Sujata Mittal highlights worries about long-term safety, lack of informed consent, and monitoring of side effects. The court has sought responses from the government and Indian Council of Medical Research, emphasizing caution while acknowledging the vaccine's role in preventing cervical cancer. The matter is set for further hearing on July 29.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans centre-left overall (Left 57%, Centre 43%, Right 0%). Overall sentiment is neutral (42/100). Lens Score 68/100.
Outlets measured: news18, indianexpress. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 1 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (35–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indianexpress broke this story on 22 Jul, 10:38 am. Other outlets followed.